YOLFTbeta
Terragen Holdings Ltd

Terragen Holdings Ltd

TGH · AU · Basic Materials / Agricultural Inputs

0.014AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.014
Open0.014
Day Range0.014 – 0.014
52-Week Range0.014 – 0.03
Volume3.39K
Market Cap18.11M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta-0.26
50-Day Avg0.0219
200-Day Avg0.021

About

Terragen Holdings Limited engages in the research, development, and commercialization of biological products for the agriculture sector in Australia and New Zealand. The company offers Mylo and Terragen Probiotic for Ruminants, which are animal feed supplement probiotics for cows and calves; and Great Land Plus, a bio-stimulant for the home garden market, supporting soil health, nutrient availability, and plant growth for lawns, gardens, and indoor plants. Terragen Holdings Limited was incorporated in 1996 and is based in Coolum Beach, Australia.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. Richard Lawrence Norton GAICD, M.B.A.
  • Employees0
  • Headquarters39 Access Crescent, Coolum Beach, QLD, Australia, 4573, Australia
  • Websitehttps://www.terragen.com.au

Leadership

  • Mr. Richard Lawrence Norton GAICD, M.B.A.CEO, MD & Director
  • Dr. Jocelyn WestChief Operating Officer
  • Mr. Daniel PearceCFO & Joint Company Secretary
  • Mr. Adam DaviesHead of Sales & Marketing
  • Dr. Paul SchoberAdvisor
  • Dr. Karen JuryHead of Research & Development
  • Dr. Paul ScottHead of Soil Health Product Development
  • Mr. Andrew WollenHead of New Product Applications Development
  • Mr. Adam GallagherJoint-Company Secretary

Financials

Income Statement

Currency: AUD2014-06-302015-06-302016-06-302017-04-302017-06-302018-04-292018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue517.19M562.65M734.56K613.98M656.36K615.43M855.69K981.01K1.53M3.65M2.89M3.28M2.14M1.62M1.43M
Growth (%)-+8.79%-99.87%+83484.46%-99.89%+93664.43%-99.86%+14.65%+56.05%+138.58%-20.85%+13.32%-34.76%-24.42%-11.34%
Cost of Revenue406.34M429.64M649.47K468.92M315.37K469.56M2.82M3.25M444.23K464.42K274.16K64.23K79.64K823.02K907.17K
Gross Profit110.85M133.00M85.09K145.06M340.99K145.88M-1.96M-2.27M1.09M3.19M2.62M3.21M2.06M792.23K524.91K
Gross Margin21.43%23.64%11.58%23.63%51.95%23.70%-228.99%-231.36%70.98%87.28%90.52%98.04%96.27%49.05%36.65%
Operating Expense85.85M83.63M3.79M90.23M4.56M95.31M2.93M1.36M6.52M10.22M8.91M7.22M6.03M5.57M5.04M
Operating Income25.00M49.38M-3.70M54.82M-4.22M50.56M-4.89M-3.63M-5.43M-7.03M-6.29M-4.01M-3.97M-4.78M-4.51M
Operating Margin4.83%8.78%-504.30%8.93%-642.91%8.22%-571.58%-370.16%-354.90%-192.61%-217.75%-122.46%-185.73%-295.94%-315.17%
EBITDA-----4.15M--4.88M-3.57M-4.97M-6.13M-5.67M-3.46M-3.50M-4.68M-4.09M
EBITDA Margin-----632.32%--570.33%-363.56%-324.68%-167.95%-196.26%-105.77%-163.69%-289.94%-285.27%
Net Income14.08M8.73M-2.38M34.24M-3.07M26.11M-3.44M-3.21M-4.93M-6.10M-5.41M-3.23M-3.01M-3.72M-3.75M
Net Income Margin2.72%1.55%-324.68%5.58%-467.24%4.24%-402.24%-327.29%-321.76%-167.02%-187.05%-98.72%-141.04%-230.54%-261.95%
R&D----633.33K-1.42M235.81K584.31K871.23K840.40K1.61M402.29K1.05M1.06M
R&D as % of Total Revenue----96.49%-165.93%24.04%38.17%23.85%29.07%49.15%18.82%65.31%74.00%
Interest Expense000036.79K063.71K19.58K29.82K22.47K18.38K17.53K28.63K32.40K37.11K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%5.61%0.00%7.45%2.00%1.95%0.62%0.64%0.54%1.34%2.01%2.59%

Balance Sheet

Currency: AUD2014-06-302015-06-302016-06-302017-04-302017-06-302018-04-292018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets651.71M658.30M2.15M703.01M1.90M751.19M3.95M22.45M18.97M14.72M9.22M6.35M6.95M8.12M10.59M
Total Liabilities375.41M369.83M677.74K220.90M1.15M268.29M1.15M1.11M1.92M1.70M1.46M1.27M1.63M1.55M1.09M
Total Equity276.30M288.47M1.47M482.11M749.41K482.91M2.79M21.34M17.04M13.02M7.76M5.08M5.32M6.57M9.50M
Cash2.04M11.96M4.00M13.41M226.74K9.35M1.68M20.34M16.38M11.64M6.67M4.17M4.54M4.70M7.36M
Total Debt--253.01M-582.04K-232.10K227.35K476.31K357.96K332.26K239.38K542.23K735.45K275.57K
Net Debt-----226.74K--1.45M-20.11M-15.90M-11.28M-6.34M-3.93M-4.00M-3.97M-7.09M

Cash Flow

Currency: AUD2014-06-302015-06-302016-06-302017-04-302017-06-302018-04-292018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow14.51M57.58M-2.10M45.58M-2.29M41.46M-2.84M-2.14M-3.89M-4.52M-4.80M-2.81M-2.32M-3.03M-3.38M
Investing Cash Flow88.00M-14.81M-48.54K-30.13M-198.81K-37.80M-198.81K-582.95K-441.45K-408.02K-118.20K-35.20K-132.93K-682.43K-176.70K
Financing Cash Flow-103.86M-32.84M2.05M-6.04M2.15M-7.72M4.49M2.88M18.88M194.92K-52.70K351.00K2.82M3.87M6.12M
Capital Expenditure18.22M17.45M52.10K28.80M198.81K32.47M198.81K637.03K441.45K408.02K175.51K103.15K24.05K4.00K116.06K
Free Cash Flow-----2.29M--3.04M-2.77M-4.33M-4.93M-4.97M-2.91M-2.35M-3.03M-3.49M
Dividends Paid12.28M12.28M12.28M12.28M-26.87M---------
FCF to OCF----100.00%-107.01%129.82%111.34%109.02%103.66%103.67%101.04%100.13%103.44%

Earnings

Report DateFeb 28, 2020Aug 31, 2020Feb 26, 2021Aug 26, 2021Feb 24, 2022Aug 30, 2022Feb 24, 2023Feb 25, 2025Aug 26, 2025
EPS Estimate0.000.000.00----0.000.00
EPS Actual-0.02-0.01-0.02-0.01-0.02-0.01-0.01-0.010.00
Surprise---------
Timing----After-hoursPre-marketAfter-hours--

Key Statistics & Ratios

Market Cap18.11M
Enterprise Value11.13M
Trailing P/E0.00
Forward P/E0.00
Price / Sales8.72
Price / Book1.91
EPS-0.01
Book Value0.012
Revenue (TTM)2.08M
Gross Profit (TTM)1.49M
EBITDA-3.57M
Profit Margin-180.54%
Operating Margin-118.95%
Return on Equity-46.68%
Return on Assets-25.84%
Shares Outstanding823.20M
Shares Float264.07M
Beta-0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Dec 9, 20242127:2113